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BACKGROUND: Currently, 2-dimensional ultrasound estimation of compare estimated fetal weight (Hadlock), estimated fetal weight3
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87fetal size rather than fetal growth is used to define fetal growth restriction,
but single estimates in late pregnancy lack sensitivity and may identify
small for gestational age rather than growth restriction. Single or longi-
tudinal measures of 3-dimensional fractional thigh volume may address
this problem.
OBJECTIVE: We sought to derive normal values for 3-dimensional
fractional thigh volume in the third trimester, determine if fractional
thigh volume is superior to 2-dimensional ultrasound biometry alone for
detecting fetal growth restriction, and determine whether individualized
growth assessment parameters have the potential to identify fetal growth
restriction remote from term delivery.
STUDYDESIGN: This was a longitudinal prospective cohort study of
115 unselected pregnancies in a tertiary referral unit (St Mary’s
Hospital, Manchester, United Kingdom). Standard 2-dimensional ul-
trasound biometry measurements were obtained, along with fractional
thigh volume measurements (based on 50% of the femoral diaphysis
length). Measurements were used to calculate estimated fetal weight
(Hadlock). Individualized growth assessment parameters and percent-
age deviations in longitudinally measured biometrics were determined
using software (iGAP; http://iGAP.research.bcm.edu). Small for
gestational age was defined <10th and fetal growth restriction <3rd
customized birthweight centile. Logistic regression was used toCite this article as: Simcox LE, Myers JE, Cole TJ, et al.
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FLA 5.4.0 DTD  YMOB11735_pro(biparietal diametereabdominal circumferenceefractional thigh vol-
ume), fractional thigh volume, and abdominal circumference for the
prediction of small for gestational age or fetal growth restriction at
birth. Screening performance was assessed using area under the
receiver operating characteristic curve.
RESULTS: There was a better correlation between fractional thigh
volume and estimated fetal weight ((biparietal diametereabdominal
circumferenceefractional thigh volume) obtained at 34-36 weeks with
birthweight than between 2-dimensional biometry measures such as
abdominal circumference and estimated fetal weight (Hadlock). There was
also a modest improvement in the detection of both small for gestational
age and fetal growth restriction using fractional thigh volumeederived
measures compared to standard 2-dimensional measurements Q(area
under receiver operating characteristic curve, 0.86; 95% confidence in-
terval, 0.79e0.94, and area under receiver operating characteristic curve,
0.92; 95% confidence interval, 0.85e0.99, respectively).
CONCLUSION: Fractional thigh volume measurements offer some
improvement over 2-dimensional biometry for the detection of late-onset
fetal growth restriction at 34-36 weeks.
Key words: estimated fetal weight, fetal growth restriction, fractional
thigh volume, small for gestational age, 3-dimensional ultrasound88
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101Introduction
The detection of fetal growth restriction
(FGR) antenatally remains a challenge,1
as undetected abnormalities in fetal
growth remain one of the strongest risk
factors for stillbirth and term perinatal
death.2-6 This problem is particularly
important in late-onset FGR, which is
usually deﬁned by ultrasound estimation
of fetal size; however, single estimates of
fetal size have a low sensitivity for the
detection of FGR.7 It is also difﬁcult to102
103
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109
110distinguish between a fetus that is
constitutionally small for gestational age
(SGA) and one that has pathological
FGR. This is important in clinical prac-
tice as it is recognized that growth-
restricted fetuses are most at risk for
adverse perinatal outcomes such as
admission to neonatal intensive care
unit, low 5-minute Apgar scores,
neurological injury, and even stillbirth or
early neonatal death.8,9 Many different
methods have been described to differ-
entiate between healthy and pathologi-
cally small fetuses including the use of
customized growth charts,10 analysis of
placental and fetal Doppler blood ﬂow,11
analysis of fetal growth velocity,12 and
the use of placentally derived bio-
markers.13 However, these methods have
been evaluated mainly in the context of
early-onset FGR <34 weeks.14 Doppler
ultrasound of umbilical artery ﬂow,MONTH 2017 Am
of  5 July 2017  8:38which is the mainstay of FGR diagnosis
and management in early-onset FGR, is
of limited use in identifying term FGR, as
this will often be normal.14 Screening
using the cerebroplacental ratio and
uterine artery pulsatility index at 35-37
weeks has demonstrated potential, but
this requires further validation.15-19
Despite the limitations of fetal sizee
based assessment, investigators have
continued to examine the use of esti-
mated fetal weight (EFW) calculated
using 2-dimensional (2D) ultrasound
measurements such as that described by
Hadlock et al.20 This screening is based
on estimations of fetal size at a single
point rather than growth velocity, so that
fetuses >10th centile, but not achieving
their growth potential, will not be iden-
tiﬁed as at risk of FGR. Unsurprisingly,
detection of SGA is better the nearer the
ultrasound scan is performed to deliveryerican Journal of Obstetrics& Gynecology 1.e1
pm  ce
FIGURE 1
---
Participant flowQ12 diagram.
BMI, body mass index; NICU, neonatal intensive care unit.
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222(70-75% at 35-37 weeks and 50-60% at
30-34 weeks for the same 10% false-
positive rate).21 These single estimates
of fetal size are also hampered by the lack1.e2 American Journal of Obstetrics& Gynecology
FLA 5.4.0 Dof adjustment for differences in indi-
vidual growth potential and therefore a
method designed to adjust for individual
growth was developed: individualizedMONTH 2017
TD  YMOB11735_proof  5 July 2017  8:38growth assessment (IGA).12 In IGA,
second-trimester growth velocity data
are used to determine Rossavik growth
models that predict individual third-
trimester growth trajectories. Three-
dimensional (3D) sonography may
allow more accurate assessment of fetal
weight and improved differentiation
between normal and pathological
growth because it includes soft-tissue
volume.22 Fetal thigh volume and the
derived fractional thigh volume (TVol)
were reported to be the most accurate
and reproducible method to estimate
birthweight.23-26 Second-trimester TVol
measurements can also be used to
generate Rossavik models for predicting
TVol and EFW growth trajectories dur-
ing the third trimester.27,28
The aim of this study was to create
reference centiles for TVol measure-
ments and to examine whether 3D
measurements of fetal soft tissues can
detect pathological deviations in fetal
growth more accurately than conven-
tional 2D measurements.
Materials and Methods
Study design
This was a longitudinal prospective
study of fetal biometry using 2D and 3D
ultrasound in 1 tertiary referral unit (St
Mary’s Hospital, Manchester, United
Kingdom). From November 2013
through July 2015, women with healthy
uncomplicated singleton pregnancies
were invited to participate. Exclusion
criteria were: fetuses subsequently
shown to have a major congenital ab-
normality, multiple pregnancies, and
maternal medical conditions known to
affect fetal growth such as maternal
diabetes, renal disease, and chronic hy-
pertension. Ultrasound scans were per-
formed for research purposes and were
not part of routine antenatal care, and
did not include clinically indicated ex-
aminations. Scan results were available
to view in the clinical records.
Participant recruitment
The study was approved by the Greater
Manchester East National Research
Ethics Committee in 2010 (Ref 10/
H1013/9) and all participants were
enrolled under signed informed consent.pm  ce
½F1
Q4
Q5
TABLE 1
Baseline demographics of study participants (n[ 115)
IBR >10th centile, n ¼ 91 FGR, n ¼ 10 SGA, n ¼ 24 P value
Maternal weight, kg 68.6 (59e74) 63.5 (61e74) 61.8 (58.8e70.5) .48
Maternal height, cm 164 (160e169) 164 (158e168) 165 (161e168) .91
Ethnicity
European 73 (80) 10 (100) 24 (100) .02
Indian 2 (2.2)
Pakistani 4 (4.4)
Caribbean 4 (4.4)
Chinese 1 (1.1)
Mixed other 2 (2.2)
Mixed Asian-European 3 (3.3)
Mixed Caribbean-European 2 (2.2)
Nulliparous 59 (65) 5 (50) 12 (50) .32
Birthweight, g 3525 (3200e3720) 2435 (2048e2720) 2733 (2455e2930) <.001
Birthweight percentile 48.9 (29.1e74.1) 1.5 (1.0e2.2) 4.7 (2.0e8.2) <.001
Gestational age at delivery, d 280 (273e287) 268 (262e277) 279 (267e289) .02
Last scan to delivery interval, wk 5.3 (4.1e6.1) 2.8 (2.3e4.9) 4.9 (2.9e6.5) .006
Data are presented as median (interquartile range) or number (%) unless otherwise specified.
P < .05 is significant; continuous variables were compared using Kruskal-Wallis test and categorical variables using Pearson c2 test.
FGR, fetal growth restriction; IBR, individual birthweight ratio; SGA, small for gestational age.
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
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334Women meeting study criteria were
approached, and given verbal and writ-
ten information when they attended for
their booking 12-week scan appoint-
ments. Pregnancies were dated using
fetal crown-rump length measurements
<14 weeks’ gestation.29 In all, 122
women were recruited to the study; all
pregnancies were prospectively moni-
tored and clinical information was
collected using a questionnaire during
each scan visit and after delivery
(Figure 1).
Ultrasonographic data collection
All 2D and 3D ultrasonography was
performed by 2 Royal College of Obste-
tricians and Gynecologistseaccredited
sonographers (L.E.S. and E.D.J. [ROR
accredited]) with 4 years of experience
with obstetric ultrasound,30 using a
Voluson E6 (GE Healthcare) with 3D 4-
to 8-Hz curvilinear probe. The study
protocol included a scan for 2D fetal
biometry (biparietal diameter [BPD],FLA 5.4.0 Dhead circumference [HC], abdominal
circumference [AC], femur length [FL]),
and 3D TVol at 14-16, 20-22, 26-28, and
34-36 weeks’ gestation. EFW (Hadlock)
was calculated as: log10 EFW ¼ 1.335 e
(0.0034 AC  FL) þ 0.0316 BPD þ
0.0457 AC þ 0.1623 FL.20 EFW centile
was calculated using Hadlock et al.20,31
Participants were not excluded from
the study if growth abnormalities were
detected at the later scans, but under-
went closer monitoring of fetal growth.
Clinicians were not blinded to clinical
information/women’s history at the time
of examination, and both participants
and clinicians were not blinded to the
results of the 2D measurements as these
appeared on the screen and were re-
ported in the woman’s notes at the time
of the scan. Automated volume mea-
surements were obtained using the Vol-
uson 4D view tool (GE Healthcare).
TVol was calculated as described by Lee
et al.32 The 3D images were archived for
later analysis in random order withMONTH 2017 Am
TD  YMOB11735_proof  5 July 2017  8:38clinicians blinded to patient identity.
Each research scan took 20 minutes with
postimage analysis for TVol measure-
ments taking 5 minutes for each volume.
Reproducibility of TVol measurements
has previously been examined in 25
women in the second trimester and 33
women in the third trimester, and across
both trimesters in 40 women in separate
studies.30,32 The intraclass correlations
were 0.992 for intraexaminer variability
and 0.943 for interexaminer
variability.30
Generation of TVol centiles
Reference centiles for TVol from 14-37
weeks’ gestation were produced using
the LMS method based on 357 scans
from fetuses with normal birthweight
outcomes (normal growth potential
and birthweight >10th centile).33 This
method summarizes the changing
distribution of a measurement with age
by 3 curves representing the median
(M), coefﬁcient of variation (S), anderican Journal of Obstetrics& Gynecology 1.e3
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FIGURE 2
---
Scatterplots of fractional thigh volumes (TVol) (n ¼ 357) during second and third trimesters of
pregnancy with fitted percentiles (5th, 10th, 25th, 50th, 75th, 90th, and 95th).
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
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446skewness (L), the latter expressed as a
Box-Cox power. Using penalized likeli-
hood, the 3 curves can be ﬁtted as cubic
splines by nonlinear regression, and the
extent of smoothing required can be
expressed in terms of smoothing
parameters or equivalent degrees of
freedom.33 A key assumption of the
method is that skewed data can be
rendered normal with suitable power
transformations. The analysis was per-
formed using the computer software
LMSchartmaker.34 Fitted L, M, and S
curves were obtained by setting the
equivalent degrees of freedom to 1, 8, and
4, respectively, and measurements were
converted to centiles using LMSgrowth.35
Biometry analysis
All data were assessed for normality of
distribution by visual inspection of his-
tograms and the Shapiro-Wilk test.
Positively skewed data were transformed
to base 10 logarithms. Linear regression
analysis was used to assess the relation-
ship with birthweight of 2D and 3D ul-
trasound measures at 26-28 and 34-36
weeks’ gestation, adjusting for gesta-
tional age at the time of the scan and at
delivery. Hindmarsh et al36 reported that
2D biometry at 30 weeks’ gestation
explained 40% of the variance in1.e4 American Journal of Obstetrics& Gynecology
FLA 5.4.0 Dbirthweight. To assess the relationship
with birthweight using 2D and 3D
biometry obtained at 34-36 weeks, a
sample size of 112 patients was calcu-
lated as sufﬁcient to identify a 20% in-
crease in the variance explained (from
40% for 2D to 60% for 3D), assuming a
type 1 error of 5% and power of 80%
using a Fisher 1 correlation z test.
SGA was deﬁned as ﬁnal customized
birthweight (individual birthweight ra-
tio [IBR]) <10th centile and FGR ﬁnal
customized birthweight (IBR) <3rd
centile using Gestation-Related Optimal
Weight (GROW) software (Version
6.7.6.1_15[UK]).37,38 Logistic regression
was used to compare the utility of 2D
and 3D ultrasound measures (EFW
[Hadlock], EFW [BPDeACeTVol], AC,
TVol) to predict SGA and FGR. The
EFW prediction model that was used for
BPD, AC, and TVol was based on a pre-
vious study by Lee et al26,39 and a sub-
sequent validation study. Screening
performance was compared using the
area under the receiver operating char-
acteristic curve (AUC) (method of
DeLong et al40). This analysis was per-
formed on 115 women with complete
data. Using data from Roma et al,41 we
calculated that 84 participants would be
needed to detect a change in theMONTH 2017
TD  YMOB11735_proof  5 July 2017  8:38detection of FGR from 60% for 2D to
72.5% for 3D (power 80%, type I error
5%).42 Statistical analysis was performed
using SPSS, Version 22 (IBM Corp,
Armonk, NY); Stata 13.1 (StataCorp,
College Station, TX); and GraphPad
Prism 6 for Windows (GraphPad Soft-
ware, San Diego, CA).
Individualized growth assessment
IGA was assessed using the publicly
available iGAP software package (http://
iGAP.research.bcm.edu), which allows
the prediction of third-trimester growth
trajectories and birthweight based on a
Rossavik model of fetal growth. Growth
models for HC, AC, femur diaphysis
length, thigh circumference, and EFW
(BPDeACeTVol) are based on linear
trends of the corresponding second-
trimester growth curves. Each individ-
ual growth curve was based on a
minimum of 2 second-trimester scans
<28 weeks separated by 4-8 weeks.
These velocity values were then
compared to reference ranges previously
calculated in a cohort of fetuses with
normal growth outcomes.28 Participants
(n¼ 0) delivering before their 34- to 36-
week scan were excluded. Expected and
observed measurements at 34-36 weeks
were compared as follows: percent
deviation¼ 100 (observed-predicted)/
predicted.
The mean of this percent deviation
was taken as a measure of the systematic
prediction error and its SD as a measure
of the random prediction error43 among
normally grown infants in this cohort.
The modiﬁed Prenatal Growth Assess-
ment Score (mPGAS), a composite
growth index that combines the percent
deviations of HC, AC, femur diaphysis
length, thigh circumference, and EFW
(BPDeACeTVol), was calculated for
each fetal growth curve. The negative
version of mPGAS was used to classify
fetuses with failing growth potential.
Fetuses outside the previously reported
95% reference range of 0% to e0.17%44
were retrospectively identiﬁed as having
abnormal growth. The Qgrowth potential
realization index for birthweight
(GPRIWT) is the ratio of the actual
birthweight to the predicted birthweight
multiplied by 100 and was calculatedpm  ce
½T1
½F2
½T2
TABLE 2
Centiles for fractional thigh volume during second and third trimesters of pregnancy, cm3
Gestational age, wk 5th 10th 25th 50th 75th 90th 95th
14 0.224 0.256 0.295 0.348 0.416 0.494 0.592
15 0.331 0.376 0.431 0.505 0.598 0.703 0.834
16 0.562 0.633 0.719 0.835 0.979 1.14 1.33
17 0.958 1.07 1.21 1.39 1.61 1.86 2.15
18 1.45 1.60 1.80 2.06 2.36 2.69 3.09
19 2.09 2.31 2.58 2.91 3.32 3.76 4.27
20 2.95 3.25 3.60 4.04 4.57 5.13 5.78
21 3.98 4.36 4.80 5.37 6.03 6.73 7.53
22 5.06 5.53 6.06 6.74 7.53 8.35 9.29
23 6.26 6.81 7.44 8.24 9.16 10.1 11.2
24 7.70 8.35 9.09 10.0 11.1 12.2 13.5
25 9.41 10.2 11.0 12.1 13.4 14.7 16.1
26 11.4 12.3 13.4 14.6 16.1 17.6 19.3
27 13.8 14.9 16.1 17.6 19.3 21.0 22.9
28 16.5 17.8 19.2 20.9 22.9 25.0 27.2
29 19.5 21.0 22.7 24.7 27.1 29.5 32.1
30 22.8 24.5 26.5 28.9 31.7 34.5 37.6
31 26.3 28.3 30.5 33.4 36.5 39.8 43.4
32 29.9 32.2 34.8 38.0 41.6 45.3 49.5
33 33.7 36.3 39.2 42.8 46.9 51.0 55.7
34 37.6 40.5 43.7 47.7 52.2 56.8 61.9
35 41.6 44.7 48.2 52.6 57.6 62.6 68.2
36 45.6 49.0 52.8 57.5 62.9 68.3 74.3
37 49.6 53.2 57.3 62.4 68.1 74.0 80.4
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
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558using measured birthweight within 24
hours of delivery and the predicted
birthweight from the third-trimester
growth curve. The predicted gestation
at delivery is at the actual gestation if
delivery is 38 weeks or at 38 weeks for
deliveries occurring >38 weeks.44 The
95% reference range for this measure-
ment is 84-118%; infants outside of this
range were also deﬁned as having
abnormal growth following birth.45
The GROW customized birthweight
centile and IGA were both included to
enable an assessment of the agreement
between the 2 methods. The GROW
method uses ﬁnal birthweight only and
thus deﬁnes FGR by this parameter alone
(adjusted for population effects ofFLA 5.4.0 Dmaternal characteristics and fetal sex),46
whereas IGA takes into account the in-
dividual growth potential of the fetus.
Results
Clinical characteristics of the 115 partici-
pants are shown in Table 1. In the normal
birthweight group with an IBR >10th
centile (n¼ 91), there was an unexplained
stillbirth and a preterm delivery at 36
weeks. Three babies were classiﬁed as large
for gestational age with an IBR >90th
centile. A total of 24 babies (21%) were
SGA and 10 babies (9%) were FGR. The
study was not powered to assess perinatal
outcomes; however, there were no
cesarean deliveries for nonreassuring fetal
status in the normal birthweight groupMONTH 2017 Am
TD  YMOB11735_proof  5 July 2017  8:38and 2 each in both the SGA and FGR
groups. There were 3 admissions to
neonatal intensive care unit in the normal
birthweight group and 1 each in the FGR
and SGA groups. There were no cases of
neonatal metabolic acidosis.
TVol measures were taken in all partic-
ipants and were normally distributed.
Figure 2 shows a scatterplot of TVol during
the second and third trimesters with ﬁtted
percentiles (5th, 10th, 25th, 50th, 75th,
90th, and 95th). The values of the TVol
centiles are given in Table 2 for reference.
Prediction of birthweight using 2D
and 3D ultrasound parameters
In isolation, 2D and 3D ultrasound
measures at 26-28 weeks’ gestation wereerican Journal of Obstetrics& Gynecology 1.e5
pm  ce
½T3
½F3
½T5
7
TABLE 3
Correlation of different ultrasound parameters at 26e28 and 34e36 weeks to birthweight
Measure
26e28 wk 34e36 wk
Coefficient (95% CI) P value R2 Coefficient (95% CI) P value R2 AIC
BPD, mm 55.7 (27.1e84.4) <.001 0.32 46.4 (23.6e69.1) <.001 0.35
HC, mm 26.1 (15.6e36.6) <.001 0.37 19.3 (11.0e27.6) <.001 0.38
AC, mm 29.5 (20.8e38.2) <.001 0.45 24.0 (18.9e29.0) <.001 0.59 1659.17
FL, mm 108.4 (65.5e151.3) <.001 0.39 50.7 (24.8e76.6) <.001 0.35 1711.66
TVol, cm3 90.3 (59.3e121.3) <.001 0.42 39.3 (32.9e45.7) <.001 0.68 1628.74
EFW (Hadlock), g 3.00 (2.24e3.76) <.001 0.51 1.36 (1.10e1.62) <.001 0.62 1648.57
EFW (BPDeACeTVol), g 2.79 (2.01e3.57) <.001 0.49 1.57 (1.36e1.77) <.001 0.76 1597.03
All linear regression models adjusted for gestational age at time of scan and birth.
AIC used to compare models confirming better model fit with EFW (BPDeACeTVol).
AC, abdominal circumference; AIC, Akaike information criterion; BPD, biparietal diameter; CI, confidence interval; EFW, estimated fetal weight; FL, femur length; HC, head circumference;
TVol, fractional thigh volume.
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
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670poor predictors of birthweight (Table 2).
For this reason, biometry measured at
26-28 weeks was not assessed further in
prediction models. The 34- to 36-week
measurements were more closely corre-
lated to birthweight: the highest R2 value
being 0.76 for EFW (BPDeACeTVol)
compared to EFW (Hadlock) (R2 ¼
0.62); comparison of Akaike and
Bayesian information criterion
conﬁrmed lower values, indicating a
better model ﬁt with EFW
(BPDeACeTVol).
Table 3 demonstrates the screening
performance of ultrasound at 34-36
weeks using the 2 EFW formulae, TVol,
and AC for the prediction of SGA and
FGR at birth. For the prediction of SGA,
the AUC values for EFW (Hadlock),
EFW (BPDeACeTVol), TVol, TVol
centile, and ACwere similar at 0.87, 0.91,
0.86, 0.86, and 0.85, respectively. The
only signiﬁcant difference between pre-
diction models was between TVol and
EFW (BPDeACeTVol) (P ¼ .04), but
EFW (BPDeACeTVol) was not signiﬁ-
cantly better than EFW (Hadlock).
For the prediction of FGR, the AUC
values were also similar apart from the
AUC for EFW (BPDeACeTVol), which
was signiﬁcantly greater than the AUC
for AC alone (0.939 vs 0.847; P ¼ .03)
(Figure 3). For individual measure-
ments, the speciﬁcity of TVol and AC
were similar (98% vs 100%), but the1.e6 American Journal of Obstetrics& Gynecology
FLA 5.4.0 Dsensitivity was higher for TVol (40% vs
20%). Comparison of TVol centile to the
absolute TVol measurement did not
improve the prediction.
IGA protocol
IGA was evaluated using the iGAP tool.
The mean percentage error for the Ros-
savik growth model of EFW (BPDe
ACeTVol) was calculated for normally
grown fetuses (excluding the above-
described 15 FGR and 3 large-for-
gestational-age fetuses, n ¼ 97). There
was a systematic error of e1.0% and a
random prediction error of 6.1%. Three
babies were identiﬁed as large by IGA
with GPRIWT values >95th conﬁdence
interval and IBR values >90. Fifteen
babies (13%) had abnormal mPGAS
(n ¼ 7), a GPRIWT for birthweight
below the reference range (n ¼ 2), or
both (n¼ 6). Of those 15 infants, 12 had
an IBR <10th centile (9 <3rd centile),
but in 3 cases the IBRs were >15
(Table 5). Among the infants classiﬁed as
FGR using the different deﬁnitions (IBR,
mPGAS, and/or GPRIWT), 15/16 were
abnormal using 2 criteria. Application of
a <10th centile threshold for TVol or
EFW (BPDeACeTVol) at 34-36 weeks
would have identiﬁed more infants with
birthweights <3rd centile than with
EFW (Hadlock) (7/10 vs 2/10; P ¼ .07)
(Table 5). There were 14 infants with a
customized birthweight centile >3rdMONTH 2017
TD  YMOB11735_proof  5 July 2017  8:38and <10th; of these, 3/14 had abnormal
mPGAS and/or GPRIWT scores sugges-
tive of true FGR. In addition, 1 baby IBR
<3rd centile had normal mPGAS/
GPRIWT/TVol, which may have indi-
cated SGA rather than FGR. The pre-
diction of FGR deﬁned using mPGAS
and/or GPRIWT is shown in
Supplementary Table 1.
Comment
Principal findings of the study
This study is the ﬁrst to deﬁne reference
TVol centiles across the third trimester of
pregnancy using the LMS method. The
ﬁtted centiles from 18-37 weeks are
similar to a previous study on TVol
centiles using a different method.32 InQ
our study at 20 weeks measurements at
the 5th, 50th, and 95th centile were 3.0
cm3, 4.0 cm3 and at 20 weeks and 45.6
cm3, 62.9 cm3 at 36 weeks, respectively.
This compares with those previously
reported (20 weeks: 3.7, 5.3, and 7.4 cm3;
36 weeks: 43.6, 62.6, and 89.9 cm3).32We
have also demonstrated that TVol is
more closely correlated to birthweight
than standard 2D measurements and
comparable to 2D EFW and AC mea-
surements for the detection of SGA and
FGR at birth. In addition, this is also the
ﬁrst report of a clinical evaluation of the
use of IGA in the prediction of SGA and
FGR. TVol was better than AC for the
prediction of FGR although the 2 EFWpm  ce
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FIGURE 3
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Area under receiver operating characteristic curve (ROC) for ultrasound examination at 34-36 weeks’
gestation for prediction of fetal growth restriction (FGR) using abdominal circumference (AC) and
estimated fetal weight (EFW) (biparietal diameter [BPD]eACefractional thigh volume [TVol]) mea-
surements. c2 Statistic is used for comparison.
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
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782formulae were comparable for the pre-
diction of FGR.
Results in context
With regard to SGA and FGR prediction,
few studies have examined the correla-
tion between ultrasound and birth-
weight at 34-36 weeks with more focus
on ultrasound EFWestimations within 7
days of delivery. Linear regression anal-
ysis of 2D and 3D ultrasound measures
at 34-36 weeks demonstrated a good
correlation with birthweight, especially
for EFW (BPDeACeTVol) (R2¼ 0.76).
This improves on the R2 values of 0.40
reported by Hindmarsh et al36 obtained
with 2D biometry at 30 weeks. A previ-
ous study examined EFW (BPDeACe
TVol) at 34-36 weeks’ gestation in 125
gestational diabetic pregnancies and
found it to be more accurate than EFW
(Hadlock).47 Other studies predicting
birthweight using 2D ultrasound EFW
and fetal thigh volume reported similar
R2 values for EFW (Hadlock) (R2 0.42) atFLA 5.4.0 D37 weeks, but no signiﬁcant association
of TVol to birthweight.48,49 However, the
latter study was small (n ¼ 42) and
observer repeatability was not tested.49
Our results demonstrated a similar
performance of TVol and 2D measure-
ments at 34-36 weeks to that of Roma
et al41 and Sovio et al.50 Roma et al41
obtained AUC at 36 weeks of 0.82 and
0.86 for the detection of FGR (birth-
weight <10th centile) and severe FGR
(birthweight <3rd centile) using 2D
EFW, with detection rates of 39% and
61%, respectively. Sovio et al50 reported
AUC at 36 weeks of 0.87 and 0.91 for
SGA<10th centile and severe SGA<3rd
centile using 2D EFW, with sensitivities
of 57% and 77%, respectively.
The use of iGAP software demon-
strated low systematic and random
prediction errors for EFW (BPDeACe
TVol) (e1.0%  6.1%), although the
systematic error is slightly higher than
previously published values using a
similar method (0.12% vs 1.0%).26MONTH 2017 Am
TD  YMOB11735_proof  5 July 2017  8:38However, in the study by Lee et al
multiple regression Qanalysis was required
to determinemodel coefﬁcients, whereas
in the iGAP model coefﬁcients are
known but Rossavik models are needed
to provide appropriate parameter values.
In this study, we also used the individu-
ally derived parameters (mPGAS and/or
GPRIWT outside 95% reference range
for birthweight) to distinguish FGR from
SGA, which has the potential advantage
of including fetuses failing to grow
appropriately born>10th centile. In this
study, there was good agreement
between the different classiﬁcations of
fetal growth using IGA and GROW
customized centiles; 9/10 infants born
<3rd centile had abnormal scores, 11/14
SGA infants had abnormal scores, and
88/91 appropriate-for-gestational-age
infants had normal scores. There were
also 3 cases of macrosomia detected by
IGA in agreement with macrosomia as
deﬁned by conventional customized
birthweight centiles.
Clinical implications
We previously demonstrated that TVol is
highly reproducible in clinical practice30
and this holds true for measurements
obtained late in the third trimester.51
Few studies evaluated the interobserver
reliability of ultrasound-derived EFW52
but this can vary by as much as 15-20%
from actual birthweight.53 Interobserver
variability for HC and ACmeasurements
also increases with gestation due to fetal
position, reduced liquor, or fetal
breathing movements that make
obtaining correct ultrasound measure-
ment planes difﬁcult.54 With the advent
of semiautomated measurement acqui-
sition and good reproducibility, TVol
may therefore be clinically useful in the
detection of FGR in late pregnancy.32
Although small numbers limited our
study, we have demonstrated that TVol
alone is comparable to 2D biometry
measures (EFW [Hadlock] and AC), for
the detection of FGR fetuses at 34-36
weeks and demonstrated that sensitivity
could perhaps be improved by the in-
clusion of this measurement. This may
be related to exponential increase in soft-
tissue mass >28-29 weeks in normally
grown, but not FGR fetuses, which iserican Journal of Obstetrics& Gynecology 1.e7
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rent data and Lee et al32).
Research implications
Several studies demonstrated the po-
tential value of IGA for the detection of
pathological growth. A study by Deter
et al,55 which examined the detection of
FGR fetuses using a combination of
birthweight, placental assessment, and
IGA, found that 14/16 fetuses (87.5%)
retrospectively classiﬁed as FGR had
abnormal GPRIWT values for birth-
weight. More recently, another study by
the same group concluded that on a
retrospective analysis of 184 SGA fetuses
the majority (67%) with both abnormal
fetal pathology growth scores (similar to
mPGAS) and negative GPRIWT values
were <5th centile for birthweight.56
While the iGAP online software pack-
age is straightforward to use and could
be introduced into clinical practice,
further validation of the IGAmethod for
the identiﬁcation of late pregnancy FGR
is required. Ideally this would include
placental markers indicative of poor
placental function FGR (eg, placental
growth factor57,58), histological exami-
nation of the placenta, and postnatal
markers of FGR such as the presence or
absence of neonatal catch-up
growth.59,60
Further work is also required to un-
derstand the importance of optimal fetal
growth in the context of ongoing child-
hood development; this research can
only progress with more accurate tools
for the detection of abnormal fetal
growth.61,62
Strengths and limitations
The strength of our study method is in
the standardized image acquisition on a
low-risk obstetric population by 2 in-
vestigators. This necessarily limited the
size of the cohort studied such that dif-
ferences in perinatal outcome could not
be assessed, although previous studies
have proven enhanced detection of FGR/
SGA to be a desirable outcome.3,50 In
addition, although TVol measurements
were concealed and analyzed without
knowledge of the pregnancy outcome,
the 2D biometry measurements results
were made available to the sonographerspm  ce
½T4
TABLE 5
Comparison of birthweight and ultrasound metrics for those infants defined as fetal growth restriction based on
individual birthweight ratio <3rd centile, modified Prenatal Growth Assessment Score <e0.17%, and/or growth
potential realization index for birthweight <84%
IBR PGAS GPRI TVol centile EFW centile EFW TVol centile
0.0a e1.4a 65.4a 0.4a 14.5 2.4a
0.9a e1.0a 83.1a 0.3a 5.2a 1.0a
1.0a e0.7a 80.9a 0.1a 12.6 1.2a
1.0a 0.0 92.9 24.0 7.8a 3.6a
1.2a 0.0 82.2a 12.0 27.6 5.6a
1.8a e0.5a 81.3a 1.0a 35.5 13.7
2.2a e1.7a 78.3a 1.0a 14.4 3.5a
2.2a 0.0 78.8a 31.0 30.8 16.5
2.3a e2.7a 94.8 2.0a 19.0 3.5a
2.7a e1.2a 85.6 6.0a 34.5 8.1a
5.5 e0.9a 94.4 3.0a 53.2 12.4
7.4 e0.9a 83.5a 2.0a 25.9 8.3a
8.9 e0.7a 100.5 0.2a 41.4 3.7a
18.1 e0.6a 98.6 1.0a 20.5 7.8a
18.8 e0.9a 116.8 2.0a 25.2 5.4a
44.7 e1.2a 99.9 13.0 70.2 50.0
EFW, estimated fetal weight; GPRI, growth potential realization index; IBR, individual birthweight ratio; PGAS, Prenatal Growth Assessment Score; TVol, fractional thigh volume.
a Measurements belowQ14 threshold demonstrating difference between different criteria. 34e36 week TVol threshold of<10th centile or EFW<10th centile (Gestation-Related Optimal Weight [GROW])
calculated using TVol would have identified 7/10 and 8/10 babies <3rd customized birthweight centile, respectively. In contrast to <10th centile (GROW) threshold using EFW (Hadlock) <10th,
which would have identified 2/10.
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
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1006and clinical care teams. This would have
prompted further monitoring for cases
of suspected SGA. Another limitation is
that the distribution of TVol measure-
ments used in generating the reference
range were clustered around 100, 150,
175, and 250 days, rather than being
uniformly distributed across gestation.
Furthermore, in the current study, we
were only able to evaluate 1 IGA
parameter (GPRIWT) to classify fetuses
with reduced growth potential. If
neonatal measurements of thigh
circumference had been available, it may
have further improved our detection of
FGR fetuses.44
Conclusions
In conclusion, our study suggests that 3D
TVol on its own is equivalent or better to
2D biometry for detecting SGA and FGR
at 34-36 weeks’ gestation. Moreover, this
study demonstrated the potential clinicalFLA 5.4.0 Dutility of IGA for the identiﬁcation of
abnormal fetal growth. There are
potential advantages in measurement
acquisition, positive predictive value, and
identiﬁcation of at-risk fetuses that
warrant larger scale study. n
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SUPPLEMENTARY TABLE 1
Screening performance for fetal growth restriction<3rd centile and fetal growth restriction classified by individualized
growth assessment methods at 34e36 weeks
FGR (mPGAS and/or GPRIWT outside 95% reference range), n ¼ 15
AUC Sensitivity, % Specificity, %
Positive
likelihood ratio
Negative
likelihood ratio PPV, % NPV, %
EFW (Hadlock) 0.90 27 96 6.7 0.76 50 90
EFW (BPDeACeTVol) 0.94 53 97 17.8 0.48 73 93
AC 0.86 27 97 8.9 0.76 57 90
TVol 0.97 73 96 18.8 0.278 73 96
AC, abdominal circumference; AUC, area under receiver operating characteristic curve; BPD, biparietal diameter; EFW, estimated fetal weight; FGR, fetal growth restriction; GPRIWT, growth potential
realization index for birthweight; mPGAS, modified Prenatal Growth Assessment Score; NPV, negative predictive value; PPV, positive predictive value; TVol, fractional thigh volume.
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
SUPPLEMENTARY TABLE 2
Glossary of terms
Term Definition
GPRI IGA indicator of neonatal growth outcome for individual anatomical parameters
GPRI ¼ (measured birth parameter value/predicted parameter value)  100
GPRIWT GPRI for birthweight
mPGAS Growth assessment score for third trimester that uses percent deviation values for HC, AC, femur diaphysis length,
thigh circumference, and EFW (BPDeACeTVol) to individual anatomical parameters at end of third trimester and
combinations of anatomical parameters at individual time points
PercentQ15 deviation ¼ [(measured value-predicted value)/predicted value]  100]
IGA Method whereby each fetus acts as its own control
Second-trimester growth velocity data are used to determine Rossavik growth models that predict individual
third-trimester growth trajectories
iGAP An online growth assessment program using IGA methods to calculate third-trimester predicted size trajectories
and birth characteristics
IBR Birthweights/fetal weights are assessed in reference to standard that is individually adjusted for physiological
pregnancy variables (maternal height, weight, parity, and ethnic group)
Postnatally, standard is also adjusted for sex of baby
AC, abdominal circumference; BPD, biparietal diameter; EFW, estimated fetal weight; GPRI, growth potential realization index; HC, head circumference; IBR, individual birthweight ratio;
IGA, individualized growth assessment; mPGAS, modified Prenatal Growth Assessment Score; TVol, fractional thigh volume.
Simcox et al. Fractional thigh volume use in third-trimester fetal assessment. Am J Obstet Gynecol 2017.
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